Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Long-Term Deferred Tax: 2009-2016

Historic Long-Term Deferred Tax for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Dec 2016 value amounting to $10.3 million.

  • Avadel Pharmaceuticals' Long-Term Deferred Tax fell 10.70% to $10.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $10.3 million, marking a year-over-year decrease of 10.70%. This contributed to the annual value of $10.3 million for FY2016, which is 10.70% down from last year.
  • As of FY2016, Avadel Pharmaceuticals' Long-Term Deferred Tax stood at $10.3 million, which was down 10.70% from $11.6 million recorded in FY2015.
  • In the past 5 years, Avadel Pharmaceuticals' Long-Term Deferred Tax ranged from a high of $13.1 million in FY2014 and a low of -$14.1 million during FY2012.
  • In the last 3 years, Avadel Pharmaceuticals' Long-Term Deferred Tax had a median value of $11.6 million in 2015 and averaged $11.7 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Long-Term Deferred Tax surged by 566.93% in 2014, and later fell by 11.61% in 2015.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Long-Term Deferred Tax stood at -$14.1 million in 2012, then soared by 80.14% to -$2.8 million in 2013, then skyrocketed by 566.93% to $13.1 million in 2014, then dropped by 11.61% to $11.6 million in 2015, then dropped by 10.70% to $10.3 million in 2016.